The Deiters Lab received an NIH R21 grant from the National Institute of Allergy and Infectious Diseases to develop new nucleic acid-based approaches to the treatment of HIV and HBV infections.
The Deiters Lab received an NIH R21 grant from the National Institute of Allergy and Infectious Diseases to develop new nucleic acid-based approaches to the treatment of HIV and HBV infections.